There has been increasing worry about possible cognitive consequences related to COVID-19 and recent case studies have revealed neurological problems in severely affected patients.1 Growing evidence shows that certain individuals…
read moreIn a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA…
read moreThe Background The acute clinical manifestations of coronavirus disease 2019 (COVID-19) have been well established. Looking beyond this acute setting, reports have suggested that some people with COVID-19 may experience…
read moreDuring the coronavirus disease 2019 (COVID-19) pandemic, vaccines have been at the forefront of the public consciousness. This is especially true for individuals with multiple sclerosis (MS), as some may…
read moreIt has been shown that everyday habits, lifestyle and stress can have a substantial influence on migraine frequency.1,2 The COVID-19 pandemic significantly disrupted the everyday life of people around the…
read moreSince December 2019, when clinicians first reported infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19), researchers have been trying to decipher the effects of the virus on…
read moreWith EAN going virtual this year, the global SARS-CoV2 pandemic was never far from the attendees’ minds. After a brief overview of the putative mechanisms for SARS-CoV2 accessing the brain,…
read more